The role of multimodality therapy for esophageal cancer

Chest Surgery Clinics of North America

Volumn 10, Issue 3, 2000, Pages 591-603

  Krasna, M J ^a   Tepper, J ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; BLEOMYCIN; CISPLATIN; FLUOROURACIL; PACLITAXEL; VINBLASTINE;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; GASTROINTESTINAL ENDOSCOPY; HUMAN; LAPAROSCOPY; MORTALITY; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; THORACOSCOPY;

CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033881396     PISSN: 10523359     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Surgery of carcinoma of the esophagus with preoperative radiation
2. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study
3. Superiority of chemoradiotherapy vs radiotherapy in patients with esophageal cancer: Final report of an intergroup randomized and confirmed study
4. Autopsy findings in squamous-cell carcinoma of the esophagus
5. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: The Japan clinical oncology group study
6. Low dose preoperative radiotherapy for carcinoma of the esophagus: Results of a randomized clinical trial
7. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma
8. Combined chemotherapy-radiotherapy ± esophagectomy in squamous cell cancer of the esophagus
9. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus
10. Infusional 5-fluorouracil and X-ray therapy for non-resectable esophageal cancer
11. Postoperative radiotherapy for carcinoma of the esophagus: A prospective randomized controlled study
12. Multimodality therapy for esophageal cancer
13. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus
14. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: Final report
15. Combined modality therapy for esophageal squamous cell carcinoma
16. The value of preoperative radiotherapy in esophageal cancer: Results of a study of EORTC
17. Preoperative radiotherapy in the treatment of the esophagus
18. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma
19. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus
20. Combined preoperative irradiation and surgery for esophageal carcinoma
21. Combined preoperative irradiation and surgery in esophageal carcinoma - Report of 408 cases
22. Surgery of esophageal carcinoma
23. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus
24. Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus
25. Is esophagectomy following upfront chemoradiotherapy safe and necessary?
26. A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: A preliminary report
27. Chemotherapy followed by operation versus operation alone in the treatment of patients with localized esophageal cancer: A preliminary report of intergroup study 113(RTOG)
28. Preoperative therapy for esophageal cancer: A randomized comparison of chemotherapy versus radiation therapy
29. Chemotherapy in oesophageal cancer
30. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: Final report of a phase III multicenter randomized controlled trial
31. Preoperative in vitro chemosensitivity test of esophageal cancer with endoscopic specimens
32. Combined thoracoscopic/laparoscopic staging of esophageal cancer
33. Thoracoscopic staging of esophageal cancer: A prospective multi-institutional trial
34. Advances in staging of esophageal carcinoma
35. Neoadjuvant therapy of squamous cell carcinoma of the esophagus: Role of resection and benefit in partial responders
36. Preoperative radiotherapy for carcinoma of the esophagus
37. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: A prospective randomized trial
38. Computerized tomographic prediction of extraluminal spread and prognostic implications of lesion width in esophageal carcinoma
39. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus
40. Measure for improving therapeutic results of esophageal carcinoma in stage III: Preoperative radiotherapy
41. Autopsy findings in 111 cases of esophageal cancer
42. The significance of thoracoscopy/laparoscopy in staging of esophageal cancer patients with or without preoperative chemotherapy/radiotherapy
43. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: A report of 206 patients
44. Surgical treatment combined with preoperative concentrated irradiation
45. Multimodality therapy for adenocarcinoma of the esophagus
46. Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of preoperative radiotherapy and chemotherapy: The second Scandinavian trial in esophageal cancer
47. A prospective comparison of laparoscopy and imaging in the staging of esophagogastric cancer before surgery
48. Mediastinal lymph node metastasis from esophageal carcinoma: CT assessment with pathologic correlation
49. Preoperative chemotherapy for esophageal cancer based on chemosensitivity testing
50. Chemotherapy, radiation therapy, and resection for carcinoma of the esophagus
51. Cancer statistics, 1996
52. The value of radiotherapy in the management of esophageal cancer
53. Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037)
54. Improved survival in squamous esophageal cancer
55. Esophageal ultrasound and the preoperative staging of carcinoma of the esophagus
56. Comparison of three treatment strategies for esophageal cancer within a single institution
57. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus
58. Neoadjuvant paclitaxel, cisplatin and radiation for esophageal cancer
59. Flow cytometric DNA analysis does not predict the radiochemoresponsiveness of esophageal cancer
60. Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus
61. A combined modality approach to the management of oesophageal cancer
62. Thoracoscopic staging and surgical therapy for esophageal cancer
63. Surgical staging prior to chemoradiation followed by esophagectomy: A preliminary analysis of a single institutional experience with esophageal cancer
64. Staging esophageal carcinoma II: CT and MRI
65. Preoperative TNM classification of esophageal carcinoma by endoscopy
66. Downstaging of esophageal cancer after preoperative radiation and chemotherapy
67. A comparison of multimodality therapy and surgery for esophageal adenocarcinoma
68. Combined-modality therapy for esophageal cancer: Phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy
69. Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: A phase I and II study
70. A randomized trial comparing surgery to preoperative concomitant chemoradiation plus surgery in patients with resectable esophageal cancer: Updated analysis